| |
AF without thrombus
|
AF with thrombus
|
p-value
|
|---|
| |
(n = 125)
|
(n = 15)
| |
|---|
|
Clinical parameters
| | | |
|
Age (year)
|
62.1 ± 9.6
|
65.3 ± 9.0
|
0.23
|
|
Male, n (%)
|
93 (74)
|
12 (80)
|
0.64
|
|
Smoking, n (%)
|
21 (17)
|
5 (33)
|
0.16
|
|
Diabetes Mellitus, n (%)
|
9 (7)
|
1 (7)
|
>0.99
|
|
Hypertension, n (%)
|
56 (45)
|
10 (67)
|
0.11
|
|
Dyslipidemia, n (%)
|
27 (21)
|
1 (7)
|
0.30
|
|
CHADS2 score = 1
|
88 (71)
|
14 (93)
|
0.059
|
|
AF duration (year)
|
5.9 ± 5.7
|
6.3 ± 3.4
|
0.83
|
|
PT-INR
|
1.89 ± 0.49
|
1.84 ± 0.35
|
0.65
|
|
PT-INR met guideline, n (%)
|
68 (54)
|
11 (73)
|
0.18
|
|
Echocardiographic parameters
|
|
LVEF (%)
|
59.1 ± 6.6
|
57.3 ± 4.8
|
0.29
|
|
LAD (mm)
|
46.0 ± 6.7
|
49.5 ± 7.5
|
0.064
|
|
Maximum LAA volume (ml)
|
10.2 ± 4.7
|
17.9 ± 8.1
|
<0.001
|
|
Minimum LAA volume (ml)
|
7.0 ± 3.8
|
14.8 ± 7.1
|
<0.001
|
|
SEC score (0-4 grade)
|
1 (1 – 1)
|
1 (1 – 2)
|
0.047
|
|
LAAPV (cm/sec)
|
31.9 ± 12.2
|
23.0 ± 8.3
|
0.007
|
|
LAA peak longitudinal strain
|
9.3 ± 5.6
|
2.5 ± 1.5
|
<0.001
|
|
LAAEF (%)
|
33.5 ± 10.7
|
17.9 ± 3.6
|
<0.001
|
- Abbreviations as in Table1.
